DUBLIN--(BUSINESS WIRE)--The "Precision Medicine and Health IT: New Data, New Challenges" report has been added to ResearchAndMarkets.com's offering.
Precision medicine (PM) is slowly entering the mainstream of health and medical discourse but is still a term in need of concise definition to move beyond the origins in genomics to the present, where PM must also encompass population health management.
This report discusses the broader definition of precision medicine, including the topics of pharmacogenomics, genotyping/sequencing, microbiomics, and radiomics & digital pathology. After introducing the various -omics data now being collected for PM purposes, the report looks at how EHRs and other health IT platforms are currently integrating this information (or not) and what major hurdles continue to limit the possibility of more broad implementation of precision medicine strategies.
The report goes on to discuss the role of new initiatives and technology that are intended to accelerate, or at least support, the continued adoption of precision medicine techniques in the provision of care. It closes with a series of seven vendor profiles and a brief list of other vendors to watch in the space.
Key Topics Covered:
- Key Takeaways
2. Overview of Key Components of PM
- Genotyping, Gene Sequencing, and the Microbiome
- Radiomics and Digital Pathology
- Dramatic Growth of Biological Data and Personal Data
3. Integration of -Omic Data into EHRs
- Collaboration for Integrating Data for Genomics and Clinical Care
4. Current Solutions for Integrating Genomic Data into EHRs
5. Scaling PM Data Sharing to Populations
6. AI/ML's Future Role
7. Taxonomy and Value Chain of PM Vendors
8. Future of PM and the Challenges Ahead
10. Vendor Profiles
- Health Catalyst
- Fabric Genomics
For more information about this report visit https://www.researchandmarkets.com/r/80huyo